Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings

NCT05614349 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

797

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Paxlovid
DRUG: Antioxidant

Sponsor

Unity Health Toronto

Collaborators

[object Object]
[object Object]